The melanocortin action is biased toward protection from weight loss in mice

Area of Science:

• Neuroscience
• Metabolic Regulation
• Endocrinology

Background:

• The melanocortin system is known to regulate body weight, with proposed bidirectional effects.
• Existing therapeutic strategies targeting melanocortin pathways for obesity have faced challenges.
• The precise role and directionality of melanocortin signaling in obesity remain incompletely understood.

Purpose of the Study:

• To investigate the directional influence of melanocortin signaling on body weight regulation.
• To determine if melanocortin pathway activation can reverse or prevent obesity.
• To elucidate the neural mechanisms underlying obesity predisposition related to melanocortin action.

Main Methods:

• Chronic inhibition of proopiomelanocortin (POMC) neurons and melanocortin receptor 4 (MC4R) expressing neurons in the hypothalamus.
• Chronic activation of POMC and MC4R expressing neuronal populations.
• Overexpression of MC4R, POMC, or its derived peptides to assess gain-of-function effects.

Main Results:

• Chronic inhibition of POMC or MC4R neurons resulted in significant obesity.
• Conversely, chronic activation of these neuronal populations did not lead to body weight reduction.
• Gain-of-function manipulations of the melanocortin system showed minimal impact on obesity prevention or reversal.

Conclusions:

• Melanocortin signaling exhibits a directional bias, primarily protecting against weight loss rather than promoting weight gain.
• The findings suggest that the melanocortin system's role in obesity is more complex than previously assumed.
• This study provides a neural basis for the observed predisposition to obesity development, challenging the bidirectional model.